Neo Kumfurt Caneye Moxi (5ml) is a prescription-strength veterinary ophthalmic antibiotic solution engineered for the rapid, targeted eradication of superficial ocular bacterial infections in dogs and cats. The active pharmaceutical ingredient is Moxifloxacin Hydrochloride BP (equivalent to 5 mg Moxifloxacin base / 0.5% w/v), safely preserved with Benzalkonium Chloride Solution IP (0.02% v/v) in a sterile aqueous buffered vehicle.

Moxifloxacin is a highly advanced, fourth-generation fluoroquinolone antibiotic. It works by inhibiting bacterial DNA gyrase and topoisomerase IV—two essential enzymes required for bacterial DNA replication, transcription, and repair. By disabling these mechanisms, Caneye Moxi provides rapid bactericidal action against a broad spectrum of Gram-positive and Gram-negative pathogens, including standard bacteria that have developed resistance to older generation antibiotics like ciprofloxacin or gentamicin. In companion animal medicine, this sterile drop is highly effective for clinical management of acute bacterial conjunctivitis (pink eye), bacterial keratitis, blepharitis, and infected corneal ulcers.

Clinical Advantage Note: Unlike combination ophthalmic formulations containing anti-inflammatory steroids or NSAIDs, Caneye Moxi contains only a pure antibiotic. This profile makes it significantly safer for the clinical treatment of active corneal ulcers and open eye wounds where steroid or NSAID usage would otherwise delay tissue regeneration or mask escalating structural damage.